FAQ

polyene phosphatidylcholine

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-2017
02419842017

Related topics

Related topics

3 relations

Broader (2)

Hypolipidemic AgentsPhosphatidylcholines

Narrower (1)

polyunsaturated phosphatidylcholine

Related mentions per year

Related mentions per year

1950-2018
1960198020002020
polyene phosphatidylcholine
Phosphatidylcholines
polyunsaturated phosphatidylcholine
Hypolipidemic Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Polyene phosphatidylcholine overcomes oxaliplatin resistance in human gastric cancer BGC823 cells.
Intrinsic or acquired resistance to oxaliplatin (L-OHP) is a major reason of treatment failure in gastric cancer and limits… (More)
Is this relevant?
2017
2017
Polyene Phosphatidylcholine inhibited the inflammatory response in LPS-stimulated macrophages and ameliorated the adjuvant-induced rat arthritis.
This study sought to investigate the anti-inflammatory effect of Polyene Phosphatidylcholine (PPC), a clinical drug that is used… (More)
Is this relevant?
2013
2013
Anti-inflammatory effects of total alkaloids from Rubus alceifolius Poir [corrected]. on non-alcoholic fatty liver disease through regulation of the NF-κB pathway.
We aimed to explore the anti-inflammatory effects of total alkaloids inRubus alceifolius Poir [corrected]. (TARAP) on non… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
Effect of Xuezhikang Capsule on serum tumor necrosis factor-alpha and interleukin-6 in patients with nonalcoholic fatty liver disease and hyperlipidemia.
OBJECTIVE To evaluate the effect of Xuezhikang Capsule on the serum levels of inflammatory factors such as tumor necrosis factor… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2010
2010
Treatment of non-alcoholic fatty liver disease by Qianggan Capsule.
OBJECTIVE To observe the therapeutic effect and safety of Qianggan Capsule (QGC) in treating non-alcoholic fatty liver disease… (More)
Is this relevant?
1995
1995
[The effect of polyene phosphatidylcholine administration on lipid metabolism and glucose tolerance in patients with hyperlipoproteinemia IIB].
BACKGROUND Up to now, clinical and experimental studies have brought only inconsistent data about the effectiveness of polyene… (More)
Is this relevant?
1994
1994
[The effect of polyene phosphatidylcholine (Essentiale forte) in the treatment of liver steatosis and ultrasound findings--preliminary study].
BACKGROUND Steatosis of the liver is the most frequent diffuse liver disease and its detection increased markedly due to… (More)
Is this relevant?
1992
1992
[Specificity of the effect of polyene phosphatidylcholine depending on the mode of administration and animal species].
The effects of polyene phosphatidylcholine (PPC) treatment at oral and intravenous administration to rats and rabbits in… (More)
Is this relevant?
1985
1985
Improvement of the gastric tolerance of non-steroidal anti-inflammatory drugs by polyene phosphatidylcholine (Phospholipon 100).
The effect of co-administration with polyene phosphatidylcholine (Phospholipon 100) on the oral gastrotoxicity of various non… (More)
Is this relevant?
1984
1984
Uptake and metabolism of polyene phosphatidylcholine in rat brain.
The rate and mechanism of incorporation of polyene phosphatidylcholine (PPC) and lysophosphatidylcholine into rat brain have been… (More)
Is this relevant?